ESC Premium Access

Anabolic androgenic abuse is associated with increased risk of systolic hypertension

Congress Presentation

About the speaker

Professor Morten Schou

Herlev-Gentofte University Hospital, Gentofte (Denmark)
1 presentation
0 follower

9 more presentations in this session

Long-term outcome of surgically- and medically-treated primary aldosteronism (PA) in the PA Prevalence in hYpertensives (PAPY) Study

Speaker: Professor G. Rossi (Padova, IT)

Thumbnail

Hypertensive crises treatment in the real-world: are anti-anxiety drugs effective anti-hypertensive agents?

Speaker: Associate Professor S. Perlini (Pavia, IT)

Thumbnail

Antihypertensive treatment and erectile dysfunction: a penile Doppler ultrasound study

Speaker: Doctor N. Ioakeimidis (Athens, GR)

Thumbnail

Blood pressure and mortality outocomes in hypertnesive patients with mild chronic obstructive pulmonary disease.

Speaker: Mr K. Bryniarski (Krakow, PL)

Thumbnail

Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.

Speaker: Associate Professor I. Lutay (Kyiv, UA)

Thumbnail

Access the full session

Hypertension in special conditions

Speakers: Professor M. Schou, Professor G. Rossi, Associate Professor S. Perlini, Doctor N. Ioakeimidis, Mr K. Bryniarski...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb